Publication | Closed Access

A phase II and pharmacokinetic study of SB-715992, in patients with metastatic hepatocellular carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG IND.168)

National Cancer InstituteHepatologyPhase IiMedicineLiver PhysiologyPharmacologyPathologyMetastatic Hepatocellular CarcinomaPharmacotherapyLiver CancerLiver TransplantationOncologyRadiation OncologyHepatocellular CarcinomaHealth Sciences